文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

影响危重症患者生存的干预措施对健康相关生活质量的影响:一项系统评价

Effects on health-related quality of life of interventions affecting survival in critically ill patients: a systematic review.
PubMed 文献 · Crit Care · 2022-05-06
一句话结论仅2.9%显示降低死亡率的RCT同时报告了生活质量,普伐他汀和右美托咪定改善生存与生活质量,热量限制和系统化ICU收治降低死亡率但恶化生活质量。

该系统评价检索MEDLINE/PubMed、Scopus和Embase(从建库至2021年8月),纳入所有显示能显著降低危重症患者死亡率的非手术干预RCT,评估其中报告生活质量数据的比例及生活质量变化方向。239项RCT中仅7项(2.9%)报告了生活质量结局,评估工具和时间点异质性大。4项干预对生活质量有显著影响:蛛网膜下腔出血患者使用普伐他汀、非心脏手术后老年患者使用右美托咪定可同时改善生存和生活质量;再喂养综合征患者热量限制和老年患者系统化ICU收治虽降低死亡率但负向影响生活质量。作者认为未来重症研究应纳入生活质量等患者重要结局,并按PROs声明和核心结局集收集数据。

要点

  • 239项显示降低死亡率的RCT中仅7项(2.9%)报告了生活质量数据,评估工具和时间点异质性大。
  • 蛛网膜下腔出血患者使用普伐他汀可同时改善生存和生活质量;非心脏手术后老年患者使用右美托咪定可同时改善生存和生活质量。
  • 再喂养综合征患者热量限制和老年患者系统化ICU收治虽降低死亡率,但负向影响生活质量。
  • 作者认为未来重症研究应纳入生活质量等患者重要结局,并按PROs声明和核心结局集收集数据以保证质量和可比性。

适用人群与场景

  • 所有显示能显著降低死亡率的非手术干预RCT所纳入的危重症患者。
  • 具体干预涉及人群包括:蛛网膜下腔出血患者、非心脏手术后老年患者、再喂养综合征患者、老年患者(系统化ICU收治)。

研究设计与关键结果

  • 研究类型:系统评价;检索MEDLINE/PubMed、Scopus和Embase从建库至2021年8月。
  • 纳入标准:所有显示能显著降低死亡率的非手术干预RCT。
  • 共239项RCT中,7项(2.9%)将生活质量作为评估结局报告。
  • 生活质量评估工具和时间点异质性大。
  • 4项干预对生活质量有显著影响:普伐他汀在蛛网膜下腔出血中改善生存和生活质量;右美托咪定在非心脏手术后老年患者中改善生存和生活质量;热量限制在再喂养综合征中降低死亡率但负向影响生活质量;系统化ICU收治在老年患者中降低死亡率但负向影响生活质量。

证据类型、等级与局限

  • 证据类型:系统评价。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为未来重症研究应纳入生活质量等患者重要结局,并按PROs声明和核心结局集收集数据以保证质量和可比性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Survival has been considered the cornerstone for clinical outcome evaluation in critically ill patients admitted to intensive care unit (ICU). There is evidence that ICU survivors commonly show impairments in long-term outcomes such as quality of life (QoL) considering them as the most relevant ones. In the last years, the concept of patient-important outcomes has been introduced and increasingly reported in peer-reviewed publications. In the present systematic review, we evaluated how many randomized controlled trials (RCTs) were conducted on critically ill patients and reporting a benefit on survival reported also data on QoL. All RCTs investigating nonsurgical interventions that significantly reduced mortality in critically ill patients were searched on MEDLINE/PubMed, Scopus and Embase from inception until August 2021. In a second stage, for all the included studies, the outcome QoL was investigated. The primary outcome was to evaluate how many RCTs analyzing interventions reducing mortality reported also data on QoL. The secondary endpoint was to investigate if QoL resulted improved, worsened or not modified. Data on QoL were reported as evaluated outcome in 7 of the 239 studies (2.9%). The tools to evaluate QoL and QoL time points were heterogeneous. Four interventions showed a significant impact on QoL: Two interventions improved survival and QoL (pravastatin in subarachnoid hemorrhage, dexmedetomidine in elderly patients after noncardiac surgery), while two interventions reduced mortality but negatively influenced QoL (caloric restriction in patients with refeeding syndrome and systematic ICU admission in elderly patients). In conclusion, only a minority of RCTs in which an intervention demonstrated to affect mortality in critically ill patients reported also data on QoL. Future research in critical care should include patient-important outcomes like QoL besides mortality. Data on this topic should be collected in conformity with PROs statement and core outcome sets to guarantee quality and comparability of results.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Pallanch O, Ortalda A, Pelosi P, et al. Effects on health-related quality of life of interventions affecting survival in critically ill patients: a systematic review. Crit Care. 2022. PMID: 35524315. doi:10.1186/s13054-022-03993-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。